ELAN — Elanco Animal Health Inc
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1739104 ·
Last close
$25.85
Market Cap
$12.92B
52W High
$27.98
52W Low
$19.40
ADV30
5,161,396
Next earnings
2026-11-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,265,000,000 | 720,000,000 | 84,000,000 | 18,000,000 | 13,340,000,000 | 465,000,000 | 6,712,000,000 |
| Jun 2026 | 1,368,000,000 | 798,000,000 | 118,000,000 | 54,000,000 | 13,561,000,000 | 530,000,000 | 6,973,000,000 |
| Mar 2026 | 1,371,000,000 | 785,000,000 | 169,000,000 | 57,000,000 | 13,222,000,000 | 428,000,000 | 6,722,000,000 |
| Dec 2025 | 1,144,000,000 | 589,000,000 | 19,000,000 | -276,000,000 | 13,358,000,000 | 545,000,000 | 6,811,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$617,000,000
Investing CF
$-335,000,000
Financing CF
$-310,000,000
CapEx
$-238,000,000
Dividends Paid
—
Buybacks
$-49,000,000
EPS Diluted TTM
$-0.41
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,071,000,000
Inventory
$1,769,000,000
Receivables
$1,152,000,000
ST Investments
—
EBIT TTM
$82,000,000
Pretax Income TTM
$-166,000,000
Interest Exp TTM
$248,000,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,148,000,256
EBITDA
$1,060,000,000
Free Cash Flow
$826,875,008
Enterprise Value
$16,563,265,536
Total Cash
$530,000,000
Total Debt
$4,232,999,936
Shares Out
499,621,830
Trailing EPS
$-0.30
Book Value
$13.19
ROE
-3.0%
ROA
1.6%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,715,000,000 | 252,000,000 | -232,000,000 | 13,358,000,000 | 6,811,000,000 | 6,547,000,000 | 560,000,000 |
| Dec 2024 | 4,439,000,000 | 251,000,000 | 338,000,000 | 12,614,000,000 | 6,518,000,000 | 6,096,000,000 | 541,000,000 |
| Dec 2023 | 4,417,000,000 | 326,000,000 | -1,231,000,000 | 14,362,000,000 | 8,139,000,000 | 6,223,000,000 | 271,000,000 |
| Dec 2022 | 4,411,000,000 | 384,000,000 | -78,000,000 | 15,491,000,000 | 8,202,000,000 | 7,289,000,000 | 452,000,000 |
TTM Snapshot
Revenues TTM
$5,020,000,000
NetIncome TTM
$-199,000,000
OpCashFlow TTM
—
Assets (Latest)
$13,561,000,000
Forward EPS
$1.28
Max Pain — expiry 2027-01-15
max pain strike: $21.00 · spot: $26.72 · call oi: 4,953 · put oi: 1,724
Expected Move to 2027-01-15:
±$3.25
(12.16%) —
implied range
$23.47 –
$29.97
· ATM straddle on $27.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RDY | DR REDDYS LABORATORIES LTD | $12.32B | $14.79 | — |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.33B | $58.51 | — |
| BBIO | BridgeBio Pharma, Inc. | $14.96B | $76.80 | — |
| JAZZ | Jazz Pharmaceuticals plc | $15.45B | $240.71 | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | $9.80B | $421.99 | — |
News headlines (Yahoo Finance, 1h cache)
Elanco Announces Inaugural $600 Million Share Repurchase Authorization
2026-11-19 11:27 · Yahoo
Elanco to Participate in Upcoming Investor Conferences
2026-11-18 13:22 · Yahoo
TL Foundation Backs VETmAb BIO's Serial Local Entrepreneurs to Strengthen San Diego's Economic Future
2026-11-17 13:54 · Yahoo
Dimensional U.S. Small Cap ETF (DFAS) Sells Skyworks and Elanco on Nov. 9
2026-11-11 11:03 · Yahoo
Elanco (ELAN) shares skyrocket, what you need to know
2026-11-10 07:09 · Yahoo
Elanco Animal Health: 3 Key Takeaways for Long-Term Investors
2026-11-09 12:02 · Yahoo
Elanco Animal Health (ELAN) Stock Still Looks Cheap Following Its 141% Run
2026-11-08 04:19 · Yahoo
What Just Happened With Elanco Animal Health (ELAN)?
2026-11-07 19:14 · Yahoo
Elanco Animal Health Q3 Earnings Call Highlights
2026-11-07 07:16 · Yahoo
Elanco Animal Health Inc (ELAN) (Q3 2026) Earnings Call Highlights: Revenue Up 11%, Guidance ...
2026-11-07 03:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.